These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 15977774)

  • 21. Short QT syndrome: successful prevention of sudden cardiac death in an adolescent by implantable cardioverter-defibrillator treatment for primary prophylaxis.
    Schimpf R; Bauersfeld U; Gaita F; Wolpert C
    Heart Rhythm; 2005 Apr; 2(4):416-7. PubMed ID: 15851347
    [No Abstract]   [Full Text] [Related]  

  • 22. Cardiac arrhythmias.
    Hammill SC
    J Am Coll Cardiol; 2004 Jul; 44(2 Suppl A):16A-18A. PubMed ID: 15261685
    [No Abstract]   [Full Text] [Related]  

  • 23. [Intervention tools in patients at risk of fatal arrhythmia: medical treatment or ICD. Indicators and results].
    Delise P
    G Ital Cardiol; 1999; 29 Suppl 4():40-2. PubMed ID: 10686694
    [No Abstract]   [Full Text] [Related]  

  • 24. [What information is given by controlled clinical trials (pharmacological and nonpharmacological) for anti-arrhythmia therapy in the prevention of sudden death?].
    Naccarella F; Croci F
    G Ital Cardiol; 1996 Nov; 26(11):1345-64. PubMed ID: 9036037
    [No Abstract]   [Full Text] [Related]  

  • 25. Microvolt T-wave alternans testing for ventricular arrhythmia risk stratification.
    Chow T; Joshi D
    Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):833-42. PubMed ID: 18570621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of the Wearable Cardioverter Defibrillator as a Bridge to Implantable Cardioverter Defibrillator.
    Weinstock J
    Card Electrophysiol Clin; 2018 Mar; 10(1):11-16. PubMed ID: 29428131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implantable cardioverter-defibrillator lead failure: how weak is the link?
    Brinker JA
    Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):758-9. PubMed ID: 18838965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unresolved issues in implantable cardioverter-defibrillator therapy.
    Mason PK; DiMarco JP
    Cardiol Clin; 2008 Aug; 26(3):433-9, vii. PubMed ID: 18538189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular implantable electronic devices in athletes.
    Do R; Patton KK
    Cardiovasc Ther; 2010 Oct; 28(5):327-36. PubMed ID: 20553287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Implantable cardioverter defibrillator].
    Tanaka S; Ikeshita M; Shoji T
    Kokyu To Junkan; 1993 Apr; 41(4):357-63. PubMed ID: 8516574
    [No Abstract]   [Full Text] [Related]  

  • 31. Who needs and implantable cardioverter-defibrillator? ICDs save lives, but sometimes medications and other options make more sense.
    Harv Heart Lett; 2011 Jun; 21(10):4-5. PubMed ID: 21695859
    [No Abstract]   [Full Text] [Related]  

  • 32. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A; Ghidina M
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
    [No Abstract]   [Full Text] [Related]  

  • 33. Implantable cardioverter defibrillator therapy for non-ischaemic cardiomyopathy. What is the role of programmed electrical stimulation?
    Plummer C
    Europace; 2009 Mar; 11(3):273-5. PubMed ID: 19164361
    [No Abstract]   [Full Text] [Related]  

  • 34. Confronting sudden cardiac arrest in the young competitive athlete.
    Greenwald J
    Conn Med; 2011 Feb; 75(2):107-9. PubMed ID: 21476381
    [No Abstract]   [Full Text] [Related]  

  • 35. [Indications for implantable automatic ventricular defibrillators. A report from the Heart Rhythm Group of the French Society of Cardiology].
    Aliot E; Chauvin M; Daubert JC; Frank R; Jondeau G; Leclercq JF; Le Heuzey JY;
    Arch Mal Coeur Vaiss; 2006 Feb; 99(2):141-54. PubMed ID: 16555698
    [No Abstract]   [Full Text] [Related]  

  • 36. Implantable defibrillators and cardiac resynchronization therapy in heart transplant recipients: results of a national survey.
    McDowell DL; Hauptman PJ
    J Heart Lung Transplant; 2009 Aug; 28(8):847-50. PubMed ID: 19632584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [LifeVest - a novel treatment option prior to implantable cardioverter defibrillator].
    Mustafić H; Karimzadeh S; Park CI
    Rev Med Suisse; 2017 Mar; 13(552):500-504. PubMed ID: 28714616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advancements in the management of sudden cardiac death: implantable antiarrhythmic devices.
    Bissett J; Talley JD
    J Ark Med Soc; 1995 Jun; 92(1):41-3. PubMed ID: 7615479
    [No Abstract]   [Full Text] [Related]  

  • 39. Lessons learned from neutral ICD trials.
    Nisam S; Breithardt G
    Europace; 2006 Jun; 8(6):393-7. PubMed ID: 16670114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cost of implantable defibrillators: how the perception of reality depends on perspective.
    Heidbüchel H
    Eur Heart J; 2007 Feb; 28(4):386-7. PubMed ID: 17289746
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.